Learn More
ErbB2 (HER2)
ErbB2 (HER2)
Marque: Invitrogen PV3590
Code nomenclature Nacres: NA.28
Informations supplémentaires : Poids : 0.05250kg
Description
ErbB2 (HER2) is a receptor tyrosine kinase that is overexpressed in some breast tumors. Herceptin, used in treatment of metastatic Her2-positive cancer, is monoclonal antibody targeting this kinase.Spécification
NP_004439 | |
Protein assays and analysis | |
Frozen | |
ERBB2 (HER2) | |
1mg | |
For research use only. Not for use in diagnostic procedures | |
ErbB2 (HER2), NEU | |
ERBB2 (HER2) was pre-diluted in enzyme dilution buffer and assayed in 20mM Tris (pH 7.5), 5 MnCl2, 1mM EGTA, 0.5mM Na3VO4, 5mM β-glycerophosphate, 2mM DTT, 0.01% CHAPS, 200μM ATP, 1000μg/mL poly [Glu, Tyr] 4:1 substrate and trace [32P]-γ-ATP for 10 minutes at 30°C | |
Amino acids 676-1255 | |
78nmoles of phosphate transferred to poly [Glu, Tyr] 4:1 substrate per minute per mg of total protein at 30°C. Activity determined at a final protein concentration of 8.33μg/mL | |
His Tag | |
Kinase assay |
0.33mg/mL | |
Frozen | |
68.6kDa | |
60% by SDS-PAGE | |
–80°C | |
1 Each | |
ErbB2 (HER2) | |
EGF receptor (ErbB) | |
ErbB2 (HER2) | |
Human | |
Baculovirus |
For Research Use Only. Not for use in diagnostic procedures.